Skip to content
FY'25FY'24FY'23FY'22
-$129.47M-1.3%-$127.85M-27.0%-$100.7M-13.0%-$89.12M-13.2%
$1.22M+10.2%$1.11M+7.3%$1.03M+6.8%$966K+7.7%
$25.04M+23.9%$20.21M+32.8%$15.23M+5.3%$14.46M+12.5%
-$110.97M+1.5%-$112.66M-31.5%-$85.69M-14.0%-$75.14M-26.2%
$712K-40.1%$1.19M+39.9%$849K-59.1%$2.08M+121%
$245.26M+93.8%$126.55M+47.7%$85.66M+240%$25.23M-48.7%
-$13.74M-$43.43M
-$111.68M+1.9%-$113.85M-31.6%-$86.54M-12.1%-$77.22M-27.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Oric Pharmaceuticals, Inc. generate?
Oric Pharmaceuticals, Inc. (ORIC) generated -$110.9M in operating cash flow over the trailing twelve months.
What is Oric Pharmaceuticals, Inc.'s free cash flow?
After $327.0K of capital expenditures, Oric Pharmaceuticals, Inc.'s free cash flow was -$111.2M over the trailing twelve months, up 4.4% year over year.
Where does Oric Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.